Sign in

CIK 0001711279 · Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
821080209
Phone
(412) 586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 2,144 shares (to pay taxes)
  2. 4 Shares withheld for taxes President, R&D gave up 3,057 shares (to pay taxes)
  3. 4 Shares withheld for taxes President and CEO gave up 4,350 shares (to pay taxes)
  4. 8-K Event Results of operations
  5. 10-K Report Annual Report
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 4 Open-market sale President, R&D sold 50,000 shares at an average $80.79 ($4,039,744)
  13. 4 Open-market sale President and CEO sold 50,000 shares at an average $80.79 ($4,039,744)
  14. 8-K Event Regulation FD disclosure
  15. 4 Open-market sale President, R&D sold 7,686 shares at an average $80.08 ($615,525)
  16. 4 Open-market sale President and CEO sold 7,686 shares at an average $80.08 ($615,525)
  17. 4 Open-market sale President, R&D sold 19,422 shares at an average $80.34 ($1,560,411)
  18. 4 Open-market sale President and CEO sold 19,422 shares at an average $80.34 ($1,560,411)
  19. 4 Open-market sale President, R&D sold 21,099 shares at an average $80.10 ($1,689,986)
  20. 4 Open-market sale President and CEO sold 21,099 shares at an average $80.10 ($1,689,986)

Page 13 of 26 · 513 filings